Joseph Ruane, DO
Sports Medicine · Columbus, OHNPI 1144210006
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Pacira Therapeutics, Inc. accounts for 69.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $5,771 and has fallen 99.7% since, to $17 in 2025.
Across 15 payments — averaging $876.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Therapeutics, Inc.$9K
- Hydrocision, Inc.$2K
- Lilly USA, LLC$2K
- SPR Therapeutics, Inc$341
- Stryker$116
- Abbott$19
- plus $17 from 1 others
What the payments were for
- Consulting fees$7,07554%
- Speaking & faculty fees$5,08839%
- Travel & lodging$6575%
- Food & beverage$3323%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Therapeutics, Inc. | 7 | $9,158 |
| Hydrocision, Inc. | 2 | $1,750 |
| Lilly USA, LLC | 1 | $1,750 |
| SPR Therapeutics, Inc | 2 | $341 |
| Stryker | 1 | $116 |
| Abbott | 1 | $19 |
| Vertex | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,151 in reported general payments places this provider in the 80th percentile of 278 sports medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 13 | $2,063 |
| Morphine Sulfate ErMorphine Sulfate | 15 | $1,032 |
| Celecoxib | 37 | $979 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 29 | $734 |
| Oxycodone Hcl | 23 | $726 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $488 |
| Gabapentin | 34 | $445 |
| Pregabalin | 15 | $354 |
| Meloxicam | 116 | $301 |
| Tramadol Hcl | 50 | $220 |
| Methylprednisolone | 39 | $205 |
| Diclofenac Sodium | 19 | $98 |
| Prednisone | 26 | $53 |
| Naproxen | 11 | $43 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Columbus
- David FlaniganColumbus$915K
- Julie BishopColumbus$322K
- Christopher KaedingColumbus$113K
- Jelle van der ListColumbus$34K
- Eric WelderColumbus$31K
- Kelvin LuuColumbus$22K
- Bryant WalrodColumbus$14K
- Nicholas ApseloffColumbus$13K
- Grant JonesColumbus$13K
- Elizabeth LiottaColumbus$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.